Cargando…

Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors

Combination chemoimmunotherapy (CIT) consisting of anti-CD20 has improved the progression-free survival (PFS) and overall survival (OS) of patients with chronic lymphocytic leukaemia (CLL). We performed a comprehensive synthesis of prognostic factors in patients with CLL on combined CIT with anti-CD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mkhwanazi, Zekhethelo A., Nyambuya, Tawanda M., Mfusi, Snenhlanhla A., Nkambule, Bongani B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701011/ https://www.ncbi.nlm.nih.gov/pubmed/36434612 http://dx.doi.org/10.1186/s12885-022-10223-0

Ejemplares similares

Prognostic value of CD20 antigen mediated immune checkpoint inhibition in patients with acute or chronic lymphocytic leukemia: A protocol for systematic review
por: Mkhwanazi, Zekhethelo A., et al.
Publicado: (2022)

T cell activation and cardiovascular risk in type 2 diabetes mellitus: a protocol for a systematic review and meta-analysis
por: Nyambuya, Tawanda M., et al.
Publicado: (2018)

Diet-Induced Obesity Promotes the Upregulation of Fas Expression on T-cells
por: Nyambuya, Tawanda Maurice, et al.
Publicado: (2021)

The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials
por: Ntsethe, Aviwe, et al.
Publicado: (2020)

The role of innate lymphoid cells and T helper cell activation in type 2 diabetic patients: a protocol for a systematic review and meta-analysis
por: Mxinwa, Vuyolwethu, et al.
Publicado: (2019)

Obesity-induced inflammation and insulin resistance: A mini-review on T-cells
por: Nyambuya, Tawanda Maurice, et al.
Publicado: (2019)

A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes
por: Nyambuya, Tawanda Maurice, et al.
Publicado: (2021)

Circulating innate lymphoid cell subtypes and altered cytokine profiles following an atherogenic high-fat diet
por: Mxinwa, Vuyolwethu, et al.
Publicado: (2021)

Expression of Caspase-3 in Circulating Innate Lymphoid Cells Subtypes Is Altered by Treatment with Metformin and Fluvastatin in High-Fat Diet Fed C57BL/6 Mice
por: Mxinwa, Vuyolwethu, et al.
Publicado: (2022)

The mean platelet volume and atherosclerotic cardiovascular-risk factors in adults with obesity: a systematic review and meta-analysis of observational studies
por: Nkambule, Bongani Brian, et al.
Publicado: (2022)

Immune-related adverse events associated with the use of immunotherapy in patients with B-cell lymphoblastic leukemia: A protocol for a systematic review and meta-analysis
por: Kanovengi, Bianca K., et al.
Publicado: (2023)

A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure
por: Nyawo, Thembeka A., et al.
Publicado: (2021)

Monocyte-mediated inflammation and cardiovascular risk factors in type 2 diabetes mellitus: A systematic review and meta-analysis of pre-clinical and clinical studies
por: Mokgalaboni, Kabelo, et al.
Publicado: (2020)

Body weight and its influence on hepcidin levels in patients with type 2 diabetes: A systematic review and meta-analysis of clinical studies
por: Ndevahoma, Fransina, et al.
Publicado: (2021)

The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetes
por: Ndevahoma, Fransina, et al.
Publicado: (2021)

Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
por: Smolej, Lukáš, et al.
Publicado: (2021)

PB1921: IS CHEMOIMMUNOTHERAPY (CIT) HISTORY IN THE FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKAEMIA?
por: Parbutt, Catherine, et al.
Publicado: (2023)

Prognostic markers in Chronic Lymphocytic Leukaemia - A flow cytometric analysis
por: Haq, Hala, et al.
Publicado: (2020)

Differential expression of glycoprotein IV on monocyte subsets following high-fat diet feeding and the impact of short-term low-dose aspirin treatment
por: Mokgalaboni, Kabelo, et al.
Publicado: (2020)

Natural killer cell levels in adults living with type 2 diabetes: a systematic review and meta-analysis of clinical studies
por: Mxinwa, Vuyolwethu, et al.
Publicado: (2020)

Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis
por: Nkambule, Bongani B., et al.
Publicado: (2020)

A Meta-Analysis of the Impact of Resveratrol Supplementation on Markers of Renal Function and Blood Pressure in Type 2 Diabetic Patients on Hypoglycemic Therapy
por: Nyambuya, Tawanda M., et al.
Publicado: (2020)

Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy
por: Porrazzo, Marika, et al.
Publicado: (2020)

An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy
por: Cohen, Jared A., et al.
Publicado: (2020)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia
por: Evans, Sarah S., et al.
Publicado: (2015)

Lipoprotein lipase: a new prognostic factor in chronic lymphocytic leukaemia
por: Hartman, Mariusz L., et al.
Publicado: (2013)

A simplified prognostic score for T-cell large granular lymphocyte leukaemia
por: Liu, Hailing, et al.
Publicado: (2023)

Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia
por: Gauthier, Martin, et al.
Publicado: (2019)

The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2014)

The potential of CD127 as a prognostic and residual disease marker in chronic adult T cell leukaemia/lymphoma
por: Kagdi, Huseini, et al.
Publicado: (2014)

The impact of coenzyme Q(10) on metabolic and cardiovascular disease profiles in diabetic patients: A systematic review and meta‐analysis of randomized controlled trials
por: Dludla, Phiwayinkosi V., et al.
Publicado: (2020)

An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin
por: Ziqubu, Khanyisani, et al.
Publicado: (2023)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

Drug-Induced Liver Injury: Clinical Evidence of N-Acetyl Cysteine Protective Effects
por: Ntamo, Yonela, et al.
Publicado: (2021)

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia
por: Brachtl, Gabriele, et al.
Publicado: (2013)

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
por: Cortellini, Alessio, et al.
Publicado: (2022)

Tumor-Infiltrating CD20(+) B Lymphocytes: Significance and Prognostic Implications in Oral Cancer Microenvironment
por: Suárez-Sánchez, Faustino Julián, et al.
Publicado: (2021)

High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia
por: Zarobkiewicz, Michał, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_akjr83nv4mkl614qg2o875p0bp